September 16, 2013
Scientists from the Vaccine and Gene Therapy Institute (VGTI) and the Oregon National Primate Research Center (ONPRC), alongside other researchers, have published a study entitled, “Immune Clearance of Highly Pathogenic SIV Infection” regarding HIV and the simian version called SIV.
Acknowledging that HIV and SIV are “similar”, the researchers say that this new vaccine they are devising could be a viable option for human HIV patients.
Louis Picker, professor at the VGTI said : “It’s always tough to claim eradication – there could always be a cell which we didn’t analyze that has the virus in it. But for the most part, with very stringent criteria… there was no virus left in the body of these monkeys.”
By focusing on SIVmac239, a more ‘aggressive form” of the virus, infected monkeys were expected to die within 2 years of infection.
Using a vaccine based on the cytomegalovirus (CMV), a member of the herpes family, the researchers monitored how CMV ravages the body of the monkeys.
CMV “is one of the herpesviruses. This group of viruses includes the herpes simplex viruses, varicella-zoster virus (which causes chickenpox and shingles), and Epstein-Barr virus (which causes infectious mononucleosis, also known as mono).”
The Centers for Disease Control and Prevention (CDC) states that CMV “is a common infection that is usually harmless. Once CMV is in a person’s body, it stays there for life. Among every 100 adults in the United States, 50–80 are infected with CMV by the time they are 40 years old.”
The vaccine was designed to assist the immune system while sweeping through the body to “maintain an armed force that patrols all the tissues of the body all the time – indefinitely.”
When monkeys were given the vaccine for SIV, the inoculation spread through the body fairly quickly; evidenced by the reaction in the body when monitored.
Picker said: “It could be the fact that SIV is so pathogenic that this is the best you are ever going to get. There is a battle going on, and half the time the vaccine wins and half the time it doesn’t. A marketable vaccine could be made for humans based on the technique created to cure SIV; however Picker explained: In order to make a human version we have to make sure it is absolutely safe. We have now engineered a CMV virus which generates the same immune response but has been attenuated [modified to lose its virulence] to the point where we think it is unequivocally safe.”
Thus study, according to Picker, is proof that “while they may not prevent the initial infection, they might lead to subsequent clearance, rather than the establishment of chronic infection.”
By using CMV, Picker’s team has endangered those who have a weakened immune system (WIS). This would be persons who would be endangered by receiving this vaccination because CMV causes “serious disease” in those who have WIS.
• Infants and newborns
• Organ and marrow transplant recipients
• Cancer patients
• Patients receiving immunosuppressive drugs
• HIV-infected patients
Picker’s CMV-based vaccine would endanger 1 out every 150 children born with congenital CMV, if this vaccine were to be added to the schedule of vaccines given to newborns.
This translates to an estimated 30,000 children annually who would die from CMV brought on by having received this vaccination.
The connection between SIV and HIV resides in the officical story.
Like any other good fairy tale, this one is set in a rainforest in south-east Cameroon where 80% of the meat eaten is “bushmeat”. The indigenous people consume a diet of gorilla, chimpanzee or monkey. It is estimated that an excess of 30,000 gorillas are killed in Cameroon each year for their meat.
Babila Tafon of the Ape Action Africa (AAA) a primate sanctuary claims to have found a new virus in the apes arriving at the AAA. It is a simian “foamy” virus, closely related to HIV. Tafon explains: “A recent survey confirmed this is now in humans, especially in some of those who are hunters and cutting up the apes in the south-east of the country.”
Transfer of viruses from ape to human occur when the primate bites or scratches, however, some assert that eating primate meat (although cooked) is a transferable way for the new virus to reach humans.
Professor Dominique Baudon, the director of the Cameroon Centre, blames the practice of eating bushmeat for the transfer of simian immunodeficiency virus (SIV) which then trans-mutated into HIV in humans.
Following the storyline of “HIV came out of Africa” researchers at the Wilford Hall United States Air Force Medical Center and San Antonio Military Medical Center, have concluded that people of African descent are more likely to have a genetic trait that makes them “more susceptible” to contracting the HIV virus.
Matthew Dolan, co-author of the study suggests: “The benefit that the Africans got from a mutation that gave them some resistance to malaria has, statistically at least, rendered them some increased susceptibility to HIV.”
In 60% of African-Americans and 90% of Africans, a genetic trait was identified that made HIV 40% more prevalent than in Caucasians.
Wangari Maathai, a Kenyan ecologist and Nobel Peace Prize winner, says that HIV was created deliberately in a laboratory as a biological weapon.
Maathai stated at a press conference after receipt of the Nobel Peace Prize that: “Some say that AIDS came from the monkeys, and I doubt that because we have been living with monkeys (since) time immemorial, others say it was a curse from God, but I say it cannot be that.”
Maathai maintains that HIV was created by “agents to wipe out other people . . . In fact [the HIV virus] was created by a scientist for biological warfare. Why has there been so much secrecy about AIDS? When you ask where did the virus come from, it raises a lot of flags. That makes me suspicious.”
She asserts that HIV was created for the purposes of population control in Africa.